A Very Bad Year: Hedge Funds Down More Than 4%

Jan 9 2012 | 2:36pm ET

Hedge funds closed out 2011 in fitting fashion, ending one of the industry's worst years ever with further losses.

The Hennessee Hedge Fund Index lost 0.6% in December, its seventh losing month of the year, to finish 2011 down 4.27%. All but seven of the 23 strategies and substrategies tracked by the Hennessee Group ended last year in the red, and only six of the 21 subindices reporting for December were up on the month—and none more than healthcare and biotechnology's 0.84%.

"It was a disappointing year for hedge funds as they underperformed broad market returns for the second year in a row," Hennessee's Charles Gradante said. "Hedge fund managers describe 2011 as 'more frustrating than 2008.'"

Short-biased funds enjoyed the strongest year, adding 3.95% (down 1.33% in December). Market neutral funds rose 3.71% (down 0.21% in Dec.) and fixed-income funds 3.6% (up 0.14% in Dec.). Healthcare and biotech added 1.9%, high-yield 1.59% (down 0.38% in Dec.), technology 1.22% (up 0.37% in Dec.) and merger arbitrage 0.18% (down 0.08% in Dec.).

On the other hand, emerging markets and Europe funds were hardest hit, losing 12.85% on the year (down 0.55% and 0.32% in Dec., respectively). Also a double-digit loser: Financial equities funds, which lost an average of 11.54% (down 2.45% in Dec.).


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Midtown's Plaza District Fades As Manhattan Office Landscape Shifts

Nov 22 2016 | 6:32pm ET

Lower leasing costs, more efficient office space and the hope of projecting an image...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR